502132-86-7 Usage
General Description
3-Amino-5-(2-fluorophenyl)-1H-pyrazole is a chemical compound with the molecular formula C9H8N3F. It belongs to the class of pyrazole compounds and is characterized by the presence of an amino group and a fluorophenyl group in its structure. 3-Amino-5-(2-fluorophenyl)-1H-pyrazole has potential applications in pharmaceutical research and drug design due to its biological activities and pharmacological properties. Its chemical structure and reactivity make it a valuable building block in the synthesis of various organic compounds, especially in the development of new drugs and bioactive molecules. The compound’s properties make it a topic of interest in the fields of medicinal chemistry and organic synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 502132-86-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,2,1,3 and 2 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 502132-86:
(8*5)+(7*0)+(6*2)+(5*1)+(4*3)+(3*2)+(2*8)+(1*6)=97
97 % 10 = 7
So 502132-86-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H8FN3/c10-7-4-2-1-3-6(7)8-5-9(11)13-12-8/h1-5H,(H3,11,12,13)
502132-86-7Relevant articles and documents
ANTAGONISTS OF THE ADENOSINE A2A RECEPTOR
-
Paragraph 001105-001107, (2021/11/13)
The present invention relates to compounds of formula I shown below: wherein R0, R1, R2, R3 and A are each as defined in the application. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or conditions in which adenosine A2a receptor activity is implicated, such as, for example, cancer.
NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS
-
Page/Page column 62, (2008/12/07)
The present invention provides compounds of formula (I) and compositions thereof, methods of making them, and methods of using them to modulate alpha7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders, diseases, and conditions. Provided compounds can affect, among other things, neurological, psychiatric and/or inflammatory system.
